Purpose: Benign paroxysmal positional vertigo (BPPV) may be found in patients complaining of hearing disorders. The aim of our investigation was to describe audiological findings in BPPV patients, focusing on subjects with asymmetric hearing loss (AHL), to better understand whether otoconial displacement may occur preferentially in the worst hearing ear.
Methods: A prospective study was performed on 112 BPPV patients. We divided the sample into subjects who suffered from AHL (G1) and patients with did not (G2). Data regarding vestibular symptoms, tinnitus, migraine, antivertigo drug therapy, and vascular risk factors were collected.
Results: Out of 30 AHL subjects, 83.33% of them were affected by sensorineural hearing loss (SNHL) in at least one ear, with a significant difference in the distribution of hearing loss type between groups (p = 0.0006). In 70% of cases, the ear affected by BPPV was the one with the worst hearing threshold (p = 0.02); threshold asymmetry predicted BPPV in the worst hearing ear (p = 0.03). The predictability depended neither on the hearing threshold gap between ears nor the severity of the hearing threshold in the worst ear (p > 0.05). No differences in vascular risk factors between groups were observed (p > 0.05). We evidenced a moderate correlation between age and hearing threshold (ρ = 0.43). Age did not result a predictive factor for residual dizziness or BPPV in the worst ear (p > 0.05).
Conclusions: Our study supports the likelihood of an otoconial displacement in the worse hearing ear in BPPV patients. Clinicians should start testing the worst hearing ear when managing AHL patients with suspected BPPV.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00405-023-08119-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Review of MRI Acoustic Noise Outputs and Hearing Protection Device Performance.
J Magn Reson Imaging
December 2024
MKS Consulting, Beachwood, Ohio, USA.
The acoustic noise outputs of MR equipment typically require a hearing protection device (HPD) to minimize the likelihood of patient hearing loss. Several different ways to quantify HPD performance have been developed and adopted over many years in different countries across the world (eg, NRR, SNR, SLC80). These HPD evaluations are done in controlled laboratory conditions, following different standardized methodologies, producing different performance ratings for the same HPD, and consequently of a variable relationship with achieved real-world usage performance assessments.
View Article and Find Full Text PDFPreliminary Normative Reference Values of Validated FEES Scales in Healthy Young Adults.
Laryngoscope
October 2024
Aerodigestive Research Core Laboratory, The Ohio State University, Columbus, Ohio, U.S.A.
Objectives: Limited normative reference data are available for validated outcomes of flexible endoscopic evaluation of swallowing (FEES). We aimed to examine healthy swallowing via FEES in community-dwelling healthy adults to derive a preliminary reference dataset of normative validated FEES outcomes to guide clinical interpretation and diagnostic decision-making.
Methods: Adults with no history of dysphagia-related disease underwent simultaneous videofluoroscopy and FEES imaging using a standardized 11-item bolus protocol.
Hearing Health at School: analysis of knowledge, behaviors and attitudes of Southern-Brazilian children and adolescents on noise.
Codas
August 2024
Universidade Tuiuti do Paraná - UTP - Curitiba (PR), Brasil.
Purpose: to analyze the knowledge, behaviors, and attitudes of students on noise.
Methods: We used an observational method study, in 32 Schools from Itajaí/Brazil, with a convenience sample, comprising 1,835 students, 45.7% females and 54.
Otitis media sequelae and hearing in adolescence after administration of an 11-valent conjugate pneumococcal vaccine in infancy: a prospective cohort study with long-term follow-up of the ARIVAC trial.
Lancet Child Adolesc Health
September 2024
Department of Pediatric Otorhinolaryngology, Children's Hospital Colorado, Aurora, CO, USA; Department of Otorhinolaryngology-Head and Neck Surgery, University of Colorado School of Medicine, Aurora, CO, USA.
Background: Pneumococcal conjugate vaccines (PCVs) have been shown in randomised controlled trials and epidemiological studies to prevent acute otitis media caused by vaccine serotype pneumococci, although their role in preventing complications of acute otitis media is less clear. We hypothesised that the 11-valent PCV would reduce the long-term sequelae of acute otitis media, including moderate-to-severe ear disease and hearing loss.
Methods: This prospective cohort study, referred to as 11PCV study, included follow-up after 16-20 years of children previously enrolled in 2000-04, at age 6 weeks to 6 months, in the randomised, placebo-controlled, ARIVAC trial of 11-valent PCV for the prevention of radiographical pneumonia.
Clinical Predictors of Cisplatin Chemoradiation-Induced Ototoxicity in HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study.
J Otolaryngol Head Neck Surg
July 2024
Department of Biostatistics, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Background: Cisplatin-based chemoradiation is a standard treatment for many patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC), an etiologically distinct subset of head and neck cancer. Although associated with good long-term survival, clinical risk factors for ototoxicity have been understudied in this population. This study aimed to evaluate clinical predictors associated with ototoxicity in HPV-positive OPSCC patients treated with cisplatin chemoradiation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!